PILLAR BIOSCIENCES
LIVE

Serial Number

90532969

Owner

Pillar Biosciences, Inc.

Attorney

Andrew T. Pettit

First Use Date

Sep 15, 2021

Filing Date

Feb 17, 2021

Add to watchlist:

No watchlists yet
View on USPTO

PILLAR BIOSCIENCES Trademark

Serial Number: 90532969 • Registration: 6992395

PILLAR BIOSCIENCES is a trademark filed by Pillar Biosciences, Inc. on February 17, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Pillar Biosciences, Inc. (17 trademarks)

Natick, MA 01760

Entity Type: 03

Trademark Details

Filing Date

February 17, 2021

Registration Date

February 28, 2023

First Use Anywhere

September 15, 2021

First Use in Commerce

September 15, 2021

Published for Opposition

May 10, 2022

Goods & Services

Downloadable computer software for the collection, management, and analysis of data for use in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics; downloadable computer software for analyzing biological samples; downloadable computer software for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; downloadable computer software for use with reagents and reagent kits, all for the purpose of detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, scientific diagnostics research, and medical diagnostics; downloadable computer software for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing; downloadable computer software for health and wellness assessment, namely, for use in genomic analysis; downloadable computer software for genetic and bioinformatics analysis

Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being for medical diagnostic purposes; biological and biochemical reagents and reagent kits for selectively amplifying nucleic acid fragments for medical diagnostic purposes; biological and biochemical kits comprised of diagnostic preparations for medical purposes, namely, for the diagnosis and treatment of cancer; biological and biochemical kits for medical diagnostic purposes

Data processing services for medical, clinical, and scientific purposes

Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being in the fields of scientific research, clinical research, and scientific diagnostics research; biological and biochemical reagents and reagent kits for selectively amplifying nucleic acid fragments for scientific research, clinical research, and scientific diagnostics research; biological and biochemical kits for scientific research, clinical research, and scientific diagnostics research

Providing biological sample testing services for others in the field of medical diagnostics; providing biological sample testing services for others for medical purposes, namely, for the diagnosis and treatment of cancer; providing reagent sample testing and diagnostic services for others, namely, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the field of medical diagnostics; medical testing for diagnostic and treatment purposes; health and wellness assessment services; providing health and wellness information

Software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for collecting, managing, and analyzing data in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for analyzing biological samples; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others with reagents and reagent kits, all for the purpose of detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, scientific diagnostics research, and medical diagnostics; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing; software as a service (SaaS), namely, hosting non-downloadable computer software for health and wellness assessment, namely, for genomic analysis; software as a service (SaaS), namely, hosting non-downloadable computer software for genetic and bioinformatics analysis; bioinformatics services, namely, product research and development in the field of bioinformatics; developing diagnostic testing models for others for medical, clinical, and scientific purposes; genetic testing for scientific research purposes; scientific research consulting

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 28, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 28, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 27, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 26, 2023 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 20, 2023 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Jan 19, 2023 SUPC
SOU EXTENSION 1 GRANTED
Jan 19, 2023 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 19, 2023 AITU
SOU EXTENSION 1 FILED
Jan 4, 2023 EXT1
USE AMENDMENT FILED
Jan 4, 2023 IUAF
SOU TEAS EXTENSION RECEIVED
Jan 4, 2023 EEXT
TEAS STATEMENT OF USE RECEIVED
Jan 4, 2023 EISU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 27, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Oct 27, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 27, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 27, 2022 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 5, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 10, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 10, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 20, 2022 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 7, 2022 PREV
ASSIGNED TO LIE
Apr 4, 2022 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 31, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 22, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 21, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 21, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 21, 2021 GNRN
NON-FINAL ACTION E-MAILED
Sep 21, 2021 GNRT
NON-FINAL ACTION WRITTEN
Sep 21, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 11, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 19, 2021 NWOS
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Feb 23, 2021 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Feb 23, 2021 PARI
NEW APPLICATION ENTERED
Feb 20, 2021 NWAP